Evelo Biosciences Announces Pricing of Initial Public Offering
A registration statement relating to the securities being sold in the offering has been declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Contact
617-704-2333
stefan@evelobio.com
Source: Evelo Biosciences, Inc.